Back

Plasma trimethylamine-N-oxide is associated with atrial fibrillation

27 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Biomarkers - Heart Failure Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Gard Frodahl Tveitevaag Svingen

Haukeland University Hospital, Bergen (Norway)

7 More presentations in this session

Presentation thumbnail
Doctor Y. Purmah (Birmingham, GB)
Abstract
Presentation thumbnail
Miss S. Werhahn (Berlin, DE)
Abstract
Presentation thumbnail
Associate Professor D. Pastori (Rome, IT)
Abstract Slides
Presentation thumbnail
Doctor Y. Purmah (Birmingham, GB)
Abstract
Presentation thumbnail
Doctor S. Mohanty (Austin, US)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Biomarkers - Heart Failure

The Event

Event poster

ESC Congress 2017

27 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Ttrimetyllysine and risk of new-onset atrial fibrillation in two large norwegian cohorts
17 April 2021
thumbnail
Congress Presentation
Exploring trimethylamine n-oxide's role in coronary microvascular dysfunction and prognostic outcomes in ST-elevation myocardial infarction patients
30 August 2024
thumbnail
Congress Presentation
Bacterial metabolites trimethylamine n-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure
29 June 2021
thumbnail
Congress Presentation
Plasma trimethylamine-N-oxide is an independent predictor of long-term cardiovascular mortality in patients undergoing percutaneous coronary intervention for acute coronary syndrome
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources